| 1T5Z | A:686-893 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN (LBD) WITH DHT AND A PEPTIDE DERIVED FROM ITS PHYSIOLOGICAL COACTIVATOR ARA70 |
| 1T63 | A:686-893 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN WITH DHT AND A PEPTIDE DERIVED FROM ITS PHYSIOLOGICAL COACTIVATOR GRIP1 NR BOX3 |
| 1T65 | A:686-893 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN WITH DHT AND A PEPTIDE DERIVED FORM ITS PHYSIOLOGICAL COACTIVATOR GRIP1 NR BOX 2 BOUND IN A NON-HELICAL CONFORMATION |
| 1XJ7 | A:686-893 | COMPLEX ANDROGEN RECEPTOR LBD AND RAC3 PEPTIDE |
| 1XOW | A:686-893 | CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH AN ANDROGEN RECEPTOR NH2-TERMINAL PEPTIDE, AR20-30, AND R1881 |
| 1XQ3 | A:686-893 | CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH R1881 |
| 1Z95 | A:686-893 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND-BINDING DOMAIN W741L MUTANT COMPLEX WITH R-BICALUTAMIDE |
| 2OZ7 | A:686-893 | CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR T877A MUTANT LIGAND-BINDING DOMAIN WITH CYPROTERONE ACETATE |
| 2PIO | A:686-893 | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
| 2PIP | L:686-893 | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
| 2PIQ | A:686-893 | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
| 2PIR | A:686-893 | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
| 2PIT | A:686-893 | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
| 2PIU | A:686-893 | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
| 2PIV | A:686-893 | ANDROGEN RECEPTOR WITH SMALL MOLECULE |
| 2PIW | A:686-893 | ANDROGEN RECEPTOR WITH SMALL MOLECULE |
| 2PKL | A:686-893 | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
| 2PNU | A:686-893 | CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH EM-5744 |
| 2Q7I | A:686-893 | THE WILD TYPE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND AN AR 20-30 PEPTIDE |
| 2Q7J | A:686-893 | THE WILD TYPE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND A TIF2 BOX 3 COACTIVATOR PEPTIDE 740-753 |
| 2Q7K | A:686-893 | THE ANDROGEN RECEPTOR PROSTATE CANCER MUTANT H874Y LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND AN AR 20-30 PEPTIDE |
| 2YLO | A:686-893 | TARGETING THE BINDING FUNCTION 3 SITE OF THE ANDROGEN RECEPTOR THROUGH IN SILICO MOLECULAR MODELING |
| 2YLP | A:686-893 | TARGETING THE BINDING FUNCTION 3 SITE OF THE ANDROGEN RECEPTOR THROUGH IN SILICO MOLECULAR MODELING |
| 2YLQ | A:686-893 | TARGETING THE BINDING FUNCTION 3 SITE OF THE ANDROGEN RECEPTOR THROUGH IN SILICO MOLECULAR MODELING |
| 2Z4J | A:686-893; B:115-124 | CRYSTAL STRUCTURE OF AR LBD WITH SHP PEPTIDE NR BOX 2 |
| 3L3X | A:686-893 | CRYSTAL STRUCTURE OF DHT-BOUND ANDROGEN RECEPTOR IN COMPLEX WITH THE FIRST MOTIF OF STEROID RECEPTOR COACTIVATOR 3 |
| 3L3Z | A:686-893 | CRYSTAL STRUCTURE OF DHT-BOUND ANDROGEN RECEPTOR IN COMPLEX WITH THE THIRD MOTIF OF STEROID RECEPTOR COACTIVATOR 3 |
| 3RLJ | A:686-893 | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM S-22 |
| 3RLL | A:686-893 | CRYSTAL STRUCTURE OF THE T877A ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH (S)-N-(4-CYANO-3-(TRIFLUOROMETHYL)PHENYL)-3-(4-CYANONAPHTHALEN-1-YLOXY)-2-HYDROXY-2-METHYLPROPANAMIDE |
| 1XB7 | A:320-510 | X-RAY STRUCTURE OF ERRALPHA LBD IN COMPLEX WITH A PGC-1ALPHA PEPTIDE AT 2.5A RESOLUTION |
| 2PJL | B:319-510; B:319-510 | CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR ALPHA IN COMPLEX WITH A SYNTHETIC INVERSE AGONIST REVEALS ITS NOVEL MOLECULAR MECHANISM |
| 3K6P | A:319-510 | ESTROGEN RELATED RECEPTOR ALPHA IN COMPLEX WITH AN ETHER BASED LIGAND |
| 1KV6 | B:247-450; B:247-450 | X-RAY STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR ERR3 LIGAND-BINDING DOMAIN IN THE CONSTITUTIVELY ACTIVE CONFORMATION |
| 1TFC | B:247-450; B:247-450 | CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH A STEROID RECEPTOR COACTIVATOR-1 PEPTIDE |
| 1VJB | B:247-442; B:247-442 | CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH 4-HYDROXYTAMOXIFEN |
| 2P7A | A:247-450 | CRYSTAL STRUCTURE OF ESTROGEN RELATED RECEPTOR G IN COMPLEX WITH 3-METHYL PHENOL |
| 2P7G | A:247-450 | X-RAY STRUCTURE OF ESTROGEN RELATED RECEPTOR G IN COMPLEX WITH BISPHENOL A. |
| 2P7Z | A:247-441 | ESTROGEN RELATED RECEPTOR GAMMA IN COMPLEX WITH 4-HYDROXY-TAMOXIFEN |
| 2ZAS | A:247-450 | CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEX WITH 4-ALPHA-CUMYLPHENOL, A BISPHENOL A DERIVATIVE |
| 2ZBS | A:247-450 | CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR GAMMA LIGAND BINDING DOMAIN APO FORM |
| 2ZKC | A:247-450 | CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEX WITH BISPHENOL Z |
| 1L2I | B:325-543; B:325-543 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH (R,R)-5,11-CIS-DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2,8-DIOL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE |
| 1PCG | B:325-543; B:325-543 | HELIX-STABILIZED CYCLIC PEPTIDES AS SELECTIVE INHIBITORS OF STEROID RECEPTOR-COACTIVATOR INTERACTIONS |
| 1QKT | A:325-543 | MUTANT ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL |
| 1QKU | C:325-543; C:325-543; C:325-543 | WILD TYPE ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL |
| 1SJ0 | A:325-543 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE ANTAGONIST LIGAND 4-D |
| 1X7E | B:325-543; B:325-543 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH WAY-244 |
| 1X7R | A:325-543 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH GENISTEIN |
| 1XP1 | A:325-543 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 15 |
| 1XP6 | A:325-543 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 16 |
| 1XP9 | A:325-543 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 18 |
| 1XPC | A:325-543 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 19 |
| 1XQC | D:325-543; D:325-543; D:325-543; D:325-543 | X-RAY STRUCTURE OF ERALPHA LBD BOUND TO A TETRAHYDROISOQUINOLINE SERM LIGAND AT 2.05A RESOLUTION |
| 1YIM | A:325-543 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 4 |
| 1YIN | A:325-543 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 3F |
| 2JF9 | C:325-529; C:325-529; C:325-529 | ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST |
| 2JFA | B:325-528; B:325-528 | ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH AN AFFINITY-SELECTED COREPRESSOR PEPTIDE |
| 2OCF | A:325-543 | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH ESTRADIOL AND THE E2#23 FN3 MONOBODY |
| 2OUZ | A:325-543 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA-LASOFOXIFENE COMPLEX |
| 2P15 | B:325-543; B:325-543 | CRYSTAL STRUCTURE OF THE ER ALPHA LIGAND BINDING DOMAIN WITH THE AGONIST ORTHO-TRIFLUOROMETHYLPHENYLVINYL ESTRADIOL |
| 2Q6J | B:325-543; B:325-543 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED TO A B-N SUBSTITUTED LIGAND |
| 2Q70 | B:325-528; B:325-528 | ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLXED TO A BENZOPYRAN LIGAND |
| 2QA6 | B:325-543; B:325-543 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA MUTANT 537S COMPLEXED WITH 4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL |
| 2QA8 | B:325-543; B:325-543 | CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN MUTANT 537S COMPLEXED WITH GENISTEIN |
| 2QAB | B:325-543; B:325-543 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN MUTANT 537S COMPLEXED WITH AN ETHYL INDAZOLE COMPOUND |
| 2QE4 | B:325-528; B:325-528 | ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A BENZOPYRAN AGONIST |
| 2QGT | B:325-543; B:325-543 | CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED TO AN ETHER ESTRADIOL COMPOUND |
| 2QH6 | B:325-543; B:325-543 | CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH AN OXABICYCLIC DIARYLETHYLENE COMPOUND |
| 2QR9 | B:325-543; B:325-543 | CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH AN OXABICYCLIC DERIVATIVE COMPOUND |
| 2QSE | B:325-543; B:325-543 | CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH BURNED MEAT COMPOUND 4-OH-PHIP |
| 2QXM | B:325-543; B:325-543 | CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED TO BURNED MEAT COMPOUND PHIP |
| 2QXS | B:325-543; B:325-543 | CRYSTAL STRUCTURE OF ANTAGONIZING MUTANT 536S OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED TO RALOXIFENE |
| 2QZO | B:325-543; B:325-543 | CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH WAY-169916 |
| 2R6W | B:325-543; B:325-543 | ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO A SERM |
| 2R6Y | B:325-543; B:325-543 | ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A SERM |
| 2YAT | A:325-543 | CRYSTAL STRUCTURE OF ESTRADIOL DERIVED METAL CHELATE AND ESTROGEN RECEPTOR-LIGAND BINDING DOMAIN COMPLEX |
| 3L03 | B:325-543; B:325-543 | CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE AND ESTETROL (ESTRA-1,3,5(10)-TRIENE-3,15 ALPHA, 16ALPHA,17BETA-TETROL) |
| 3OS8 | D:325-543; D:325-543; D:325-543; D:325-543 | ESTROGEN RECEPTOR |
| 3OS9 | D:325-543; D:325-543; D:325-543; D:325-543 | ESTROGEN RECEPTOR |
| 3OSA | D:325-543; D:325-543; D:325-543; D:325-543 | ESTROGEN RECEPTOR |
| 1L2J | B:277-494; B:277-494 | HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH (R, R)-5,11-CIS-DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2,8-DIOL |
| 1NDE | A:277-494 | ESTROGEN RECEPTOR BETA WITH SELECTIVE TRIAZINE MODULATOR |
| 1QKM | A:277-494 | HUMAN OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH PARTIAL AGONIST GENISTEIN |
| 1U3Q | D:277-494; D:277-494; D:277-494; D:277-494 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH CL-272 |
| 1U3R | B:277-494; B:277-494 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-338 |
| 1U3S | B:277-494; B:277-494 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-797 |
| 1X76 | B:277-494; B:277-494 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-697 |
| 1X78 | B:277-494; B:277-494 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-244 |
| 1X7B | B:277-494; B:277-494 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH ERB-041 |
| 1X7J | B:277-494; B:277-494 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH GENISTEIN |
| 1YY4 | B:277-494; B:277-494 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH 1-CHLORO-6-(4-HYDROXY-PHENYL)-NAPHTHALEN-2-OL |
| 1YYE | B:277-494; B:277-494 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-202196 |
| 1ZAF | B:277-494; B:277-494 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH 3-BROMO-6-HYDROXY-2-(4-HYDROXY-PHENYL)-INDEN-1-ONE |
| 2JJ3 | B:277-494; B:277-494 | ESTROGEN RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A BENZOPYRAN AGONIST |
| 2NV7 | B:277-494; B:277-494 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-555 |
| 2Z4B | B:277-494; B:277-494 | ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN COMPLEXED TO A BENZOPYRAN LIGAND |
| 3OLL | B:277-494; B:277-494 | CRYSTAL STRUCTURE OF PHOSPHORYLATED ESTROGEN RECEPTOR BETA LIGAND BINDING DOMAIN |
| 3OLS | B:277-494; B:277-494 | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA LIGAND BINDING DOMAIN |
| 3OMO | B:277-494; B:277-494 | FRAGMENT-BASED DESIGN OF NOVEL ESTROGEN RECEPTOR LIGANDS |
| 3OMP | B:277-494; B:277-494 | FRAGMENT-BASED DESIGN OF NOVEL ESTROGEN RECEPTOR LIGANDS |
| 3OMQ | B:277-494; B:277-494 | FRAGMENT-BASED DESIGN OF NOVEL ESTROGEN RECEPTOR LIGANDS |
| 1M2Z | D:542-753; D:542-753 | CRYSTAL STRUCTURE OF A DIMER COMPLEX OF THE HUMAN GLUCOCORTICOID RECEPTOR LIGAND-BINDING DOMAIN BOUND TO DEXAMETHASONE AND A TIF2 COACTIVATOR MOTIF |
| 1NHZ | A:542-753 | CRYSTAL STRUCTURE OF THE ANTAGONIST FORM OF GLUCOCORTICOID RECEPTOR |
| 1P93 | D:542-753; D:542-753; D:542-753; D:542-753 | CRYSTAL STRUCTURE OF THE AGONIST FORM OF GLUCOCORTICOID RECEPTOR |
| 3K22 | B:542-753; B:542-753 | GLUCOCORTICOID RECEPTOR WITH BOUND ALANINAMIDE 10 WITH TIF2 PEPTIDE |
| 3K23 | C:542-753; C:542-753; C:542-753 | GLUCOCORTICOID RECEPTOR WITH BOUND D-PROLINAMIDE 11 |
| 1PZL | A:157-352 | CRYSTAL STRUCTURE OF HNF4A LBD IN COMPLEX WITH THE LIGAND AND THE COACTIVATOR SRC-1 PEPTIDE |
| 1Y9R | B:748-960; B:748-960 | CRYSTAL STRUCTURE OF THE HUMAN MINERALOCORTICOID RECEPTOR LIGAND-BINDING DOMAIN BOUND TO DEOXYCORTICOSTERONE AND HARBORING THE S810L MUTATION RESPONSIBLE FOR A SEVERE FORM OF HYPERTENSION |
| 1YA3 | C:750-960; C:750-960; C:750-960 | CRYSTAL STRUCTURE OF THE HUMAN MINERALOCORTICOID RECEPTOR LIGAND-BINDING DOMAIN BOUND TO PROGESTERONE AND HARBORING THE S810L MUTATION RESPONSIBLE FOR A SEVERE FORM OF HYPERTENSION |
| 2OAX | F:748-960; F:748-960; F:748-960; F:748-960; F:748-960; F:748-960 | CRYSTAL STRUCTURE OF THE S810L MUTANT MINERALOCORTICOID RECEPTOR ASSOCIATED WITH SC9420 |
| 3N00 | A:432-611 | CRYSTAL STRUCTURE OF A DELETION MUTANT OF HUMAN REVERBA LIGAND BINDING DOMAIN BOUND WITH AN NCOR ID1 PEPTIDE DETERMINED TO 2.60A |
| 2V0V | D:398-576; D:398-576; D:398-576; D:398-576 | CRYSTAL STRUCTURE OF REV-ERB BETA |
| 2V7C | B:397-572; B:397-572 | CRYSTAL STRUCTURE OF REV-ERB BETA |
| 1P8D | B:254-449; B:254-449 | X-RAY CRYSTAL STRUCTURE OF LXR LIGAND BINDING DOMAIN WITH 24(S),25-EPOXYCHOLESTEROL |
| 1PQ6 | D:254-449; D:254-449; D:254-449; D:254-449 | HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEX |
| 1PQ9 | D:260-449; D:260-449; D:260-449; D:260-449 | HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 COMPLEX |
| 1PQC | D:260-449; D:260-449; D:260-449; D:260-449 | HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 |
| 1UPV | A:254-449 | CRYSTAL STRUCTURE OF THE HUMAN LIVER X RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST |
| 1UPW | A:254-449 | CRYSTAL STRUCTURE OF THE HUMAN LIVER X RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST |
| 3KFC | D:254-449; D:254-449; D:254-449; D:254-449 | COMPLEX STRUCTURE OF LXR WITH AN AGONIST |
| 3L0E | A:254-449 | X-RAY CRYSTAL STRUCTURE OF A POTENT LIVER X RECEPTOR MODULATOR |
| 3L1B | A:261-468 | COMPLEX STRUCTURE OF FXR LIGAND-BINDING DOMAIN WITH A TETRAHYDROAZEPINOINDOLE COMPOUND |
| 3OKH | A:261-468 | CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH 2-(4-CHLOROPHENYL)-1-[(1S)-1-CYCLOHEXYL-2-(CYCLOHEXYLAMINO)-2-OXOETHYL]-1H-BENZIMIDAZOLE-6-CARBOXYLIC ACID |
| 3OKI | C:261-468; C:261-468 | CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH (2S)-2-[2-(4-CHLOROPHENYL)-1H-BENZIMIDAZOL-1-YL]-N,2-DICYCLOHEXYLETHANAMIDE |
| 3OLF | C:261-468; C:261-468 | CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH 4-({(2S)-2-[2-(4-CHLOROPHENYL)-5,6-DIFLUORO-1H-BENZIMIDAZOL-1-YL]-2-CYCLOHEXYLACETYL}AMINO)-3-METHYLBENZOIC ACID |
| 3OMK | C:261-468; C:261-468 | CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH (2S)-2-[2-(4-CHLOROPHENYL)-5,6-DIFLUORO-1H-BENZIMIDAZOL-1-YL]-2-CYCLOHEXYL-N-(2-METHYLPHENYL)ETHANAMIDE |
| 3OMM | C:261-468; C:261-468 | CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH 4-({(2S)-2-[2-(4-CHLOROPHENYL)-5,6-DIFLUORO-1H-BENZIMIDAZOL-1-YL]-2-CYCLOHEXYLACETYL}AMINO)-3-FLUOROBENZOIC ACID |
| 3OOF | C:261-468; C:261-468 | CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH 4-({(2S)-2-[2-(4-CHLOROPHENYL)-5,6-DIFLUORO-1H-BENZIMIDAZOL-1-YL]-2-CYCLOHEXYLACETYL}AMINO)BENZOIC ACID |
| 3OOK | C:261-468; C:261-468 | CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH 4-({(2S)-2-[2-(4-CHLOROPHENYL)-5,6-DIFLUORO-1H-BENZIMIDAZOL-1-YL]-2-CYCLOHEXYLACETYL}AMINO)-3,5-DIFLUOROBENZOIC ACID |
| 1M13 | A:223-426 | CRYSTAL STRUCTURE OF THE HUMAN PREGANE X RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH HYPERFORIN, A CONSTITUENT OF ST. JOHN'S WORT |
| 1NRL | B:223-426; B:223-426 | CRYSTAL STRUCTURE OF THE HUMAN PXR-LBD IN COMPLEX WITH AN SRC-1 COACTIVATOR PEPTIDE AND SR12813 |
| 1SKX | A:223-426 | STRUCTURAL DISORDER IN THE COMPLEX OF HUMAN PXR AND THE MACROLIDE ANTIBIOTIC RIFAMPICIN |
| 2O9I | B:1223-1426; B:1223-1426 | CRYSTAL STRUCTURE OF THE HUMAN PREGNANE X RECEPTOR LBD IN COMPLEX WITH AN SRC-1 COACTIVATOR PEPTIDE AND T0901317 |
| 2QNV | A:223-426 | CRYSTAL STRUCTURE OF THE PREGNANE X RECEPTOR BOUND TO COLUPULONE |
| 1XV9 | D:154-342; D:154-342; C:251-442; C:251-442 | CRYSTAL STRUCTURE OF CAR/RXR HETERODIMER BOUND WITH SRC1 PEPTIDE, FATTY ACID, AND 5B-PREGNANE-3,20-DIONE. |
| 1XVP | D:154-342; D:154-342; C:251-442; C:251-442 | CRYSTAL STRUCTURE OF CAR/RXR HETERODIMER BOUND WITH SRC1 PEPTIDE, FATTY ACID AND CITCO |
| 3P0U | B:385-586; B:385-586 | CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN TESTICULAR RECEPTOR 4 |
| 1OVL | F:385-587; F:385-587; F:385-587; F:385-587; F:385-587; F:385-587 | CRYSTAL STRUCTURE OF NURR1 LBD |
| 1YUC | B:324-535; B:324-535 | HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, BOUND TO PHOSPHOLIPID AND A FRAGMENT OF HUMAN SHP |
| 1ZDU | A:278-489 | THE CRYSTAL STRUCTURE OF HUMAN LIVER RECEPTOR HOMOLOGUE-1 |
| 3PLZ | B:324-535; B:324-535 | HUMAN LRH1 LBD BOUND TO GR470 |
| 1K7L | G:241-450; G:241-450; G:241-450; G:241-450 | THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PPARALPHA LIGAND BINDING DOMAIN BOUND WITH GW409544 AND A CO-ACTIVATOR PEPTIDE. |
| 1KKQ | D:241-450; D:241-450; D:241-450; D:241-450 | CRYSTAL STRUCTURE OF THE HUMAN PPAR-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH AN ANTAGONIST GW6471 AND A SMRT COREPRESSOR MOTIF |
| 2NPA | C:241-450; C:241-450 | THE CRYSTAL STRUCTURE OF THE HUMAN PPARAPLPHA LIGAND BINDING DOMAIN IN COMPLEX WITH A A-HYDROXYIMINO PHENYLPROPANOIC ACID |
| 2P54 | A:241-450 | A CRYSTAL STRUCTURE OF PPAR ALPHA BOUND WITH SRC1 PEPTIDE AND GW735 |
| 2REW | A:241-450 | CRYSTAL STRUCTURE OF PPARALPHA LIGAND BINDING DOMAIN WITH BMS-631707 |
| 2ZNN | A:241-450 | HUMAN PPAR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST TIPP703 |
| 3KDT | B:241-450; B:241-450 | CRYSTAL STRUCTURE OF PEROXISOME PROLIFERATOR-ACTIVATEDECEPTOR ALPHA (PPARALPHA) COMPLEX WITH N-3-((2-(4-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL)METHOXY)BENZYL)-N-(METHOXYCARBONYL)GLYCINE |
| 3KDU | B:241-450; B:241-450 | CRYSTAL STRUCTURE OF PEROXISOME PROLIFERATOR-ACTIVATEDECEPTOR ALPHA (PPARALPHA) COMPLEX WITH N-3-((2-(4-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL)METHOXY)BENZYL)-N-((4-METHYLPHENOXY)CARBONYL)GLYCINE |
| 2Q5G | B:276-459; B:276-459 | LIGAND BINDING DOMAIN OF PPAR DELTA RECEPTOR IN COMPLEX WITH A PARTIAL AGONIST |
| 2XYJ | B:234-427; B:234-427 | NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA AGONISTS WITH HIGH POTENCY AND IN-VIVO EFFICACY |
| 2XYW | B:230-427; B:230-427 | NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA AGONISTS WITH HIGH POTENCY AND IN-VIVO EFFICACY |
| 2XYX | B:230-427; B:230-427 | NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA AGONISTS WITH HIGH POTENCY AND IN-VIVO EFFICACY |
| 2ZNP | B:271-463; B:271-463 | HUMAN PPAR DELTA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST TIPP204 |
| 2ZNQ | B:271-463; B:271-463 | HUMAN PPAR DELTA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST TIPP401 |
| 3OZ0 | A:266-463 | PPAR DELTA IN COMPLEX WITH AZPPARD02 |
| 1K74 | D:266-463; A:251-442 | THE 2.3 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN PPARGAMMA AND RXRALPHA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH GW409544 AND 9-CIS RETINOIC ACID AND CO-ACTIVATOR PEPTIDES. |
| 1KNU | B:266-460; B:266-460 | LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA IN COMPLEX WITH A SYNTHETIC AGONIST |
| 1NYX | B:266-461; B:266-461 | LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA IN COMPLEX WITH AN AGONIST |
| 1PRG | B:266-463; B:266-463 | LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA |
| 1RDT | D:276-463; A:263-442 | CRYSTAL STRUCTURE OF A NEW REXINOID BOUND TO THE RXRALPHA LIGAND BINDING DOAMIN IN THE RXRALPHA/PPARGAMMA HETERODIMER |
| 1WM0 | X:266-463 | PPARGAMMA IN COMPLEX WITH A 2-BABA COMPOUND |
| 1ZEO | B:276-460; B:276-460 | CRYSTAL STRUCTURE OF HUMAN PPAR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH AN ALPHA-ARYLOXYPHENYLACETIC ACID AGONIST |
| 2OM9 | D:266-463; D:266-463; D:266-463; D:266-463 | AJULEMIC ACID, A SYNTHETIC CANNABINOID BOUND TO PPAR GAMMA |
| 2P4Y | B:278-453; B:278-453 | CRYSTAL STRUCTURE OF HUMAN PPAR-GAMMA-LIGAND BINDING DOMAIN COMPLEXED WITH AN INDOLE-BASED MODULATOR |
| 2POB | B:273-461; B:273-461 | PPARGAMMA LIGAND BINDING DOMAIN COMPLEXED WITH A FARGLITAZAR ANALOGUE GW4709 |
| 2Q59 | B:266-456; B:266-456 | CRYSTAL STRUCTURE OF PPARGAMMA LBD BOUND TO FULL AGONIST MRL20 |
| 2Q5P | B:266-456; B:266-456 | CRYSTAL STRUCTURE OF PPARGAMMA BOUND TO PARTIAL AGONIST MRL24 |
| 2Q5S | B:266-463; B:266-463 | CRYSTAL STRUCTURE OF PPARGAMMA BOUND TO PARTIAL AGONIST NTZDPA |
| 2Q61 | B:266-463; B:266-463 | CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN BOUND TO PARTIAL AGONIST SR145 |
| 2Q6R | B:266-458; B:266-458 | CRYSTAL STRUCTURE OF PPAR GAMMA COMPLEXED WITH PARTIAL AGONIST SF147 |
| 2Q6S | B:266-456; B:266-456 | 2.4 ANGSTROM CRYSTAL STRUCTURE OF PPAR GAMMA COMPLEXED TO BVT.13 WITHOUT CO-ACTIVATOR PEPTIDES |
| 2Q8S | B:275-461; B:275-461 | X-RAY CRYSTAL STRUCTURE OF THE NUCLEAR HORMONE RECEPTOR PPAR-GAMMA IN A COMPLEX WITH A PPAR GAMMA/ALPHA DUAL AGONIST |
| 2QMV | A:266-463 | HIGH RESOLUTION STRUCTURE OF PEROXISONE PROLIFERATION-ACTIVATED RECEPTOR GAMMA AND CHARACTERISATION OF ITS INTERACTION WITH THE CO-ACTIVATOR TRANSCRIPTIONAL INTERMEDIARY FACTOR 2 |
| 2VSR | B:266-459; B:266-459 | HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 9-(S)-HODE |
| 2VST | B:266-459; B:266-459 | HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 13-(S)-HODE |
| 2VV1 | B:276-459; B:276-459 | HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 4-HDHA |
| 2VV2 | B:266-461; B:266-461 | HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 5-HEPA |
| 2VV3 | B:276-459; B:276-459 | HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 4-OXODHA |
| 2VV4 | B:275-459; B:275-459 | HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 6-OXOOTE |
| 2ZK0 | B:266-461; B:266-461 | HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN |
| 2ZK1 | B:266-461; B:266-461 | HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 15-DEOXY-DELTA12,14-PROSTAGLANDIN J2 |
| 2ZK2 | B:266-461; B:266-461 | HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH GLUTATHION CONJUGATED 15-DEOXY-DELTA12,14-PROSTAGLANDIN J2 |
| 2ZK3 | B:266-461; B:266-461 | HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 8-OXO-EICOSATETRAENOIC ACID |
| 2ZK4 | B:266-461; B:266-461 | HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 15-OXO-EICOSATETRAENOIC ACID |
| 2ZK5 | B:266-461; B:266-461 | HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH NITRO-233 |
| 2ZK6 | B:266-461; B:266-461 | HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH C8-BODIPY |
| 2ZNO | B:274-461; B:274-461 | HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST TIPP703 |
| 2ZVT | B:266-461; B:266-461 | CYS285SER MUTANT PPARGAMMA LIGAND-BINDING DOMAIN COMPLEXED WITH 15-DEOXY-DELTA12,14-PROSTAGLANDIN J2 |
| 3K8S | B:275-463; B:275-463 | CRYSTAL STRUCTURE OF PPARG IN COMPLEX WITH T2384 |
| 3KMG | D:275-463; D:275-463 | THE X-RAY CRYSTAL STRUCTURE OF PPAR-GAMMA IN COMPLEX WITH AN INDOLE DERIVATIVE MODULATOR, GSK538, AND AN SRC-1 PEPTIDE |
| 3LMP | A:272-463 | CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH A CERCOSPORAMIDE DERIVATIVE MODULATOR |
| 3NOA | B:266-463; B:266-463 | CRYSTAL STRUCTURE OF HUMAN PPAR-GAMMA LIGAND BINDING DOMAIN COMPLEX WITH A POTENCY IMPROVED AGONIST |
| 3OSI | B:275-460; B:275-460 | CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH TETRACHLORO-BISPHENOL A (TCBPA) |
| 3OSW | B:275-460; B:275-460 | CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH TETRABROMO-BISPHENOL A (TBBPA) |
| 3PBA | B:266-460; B:266-460 | CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH MONOSULFATE TETRABROMO-BISPHENOL A (MONOTBBPA) |
| 3PRG | A:274-463 | LIGAND BINDING DOMAIN OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR |
| 1SR7 | B:698-909; B:698-909 | PROGESTERONE RECEPTOR HORMONE BINDING DOMAIN WITH BOUND MOMETASONE FUROATE |
| 1ZUC | B:698-909; B:698-909 | PROGESTERONE RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH THE NONSTEROIDAL AGONIST TANAPROGET |
| 2OVH | A:698-909 | PROGESTERONE RECEPTOR WITH BOUND ASOPRISNIL AND A PEPTIDE FROM THE CO-REPRESSOR SMRT |
| 2OVM | A:698-909 | PROGESTERONE RECEPTOR WITH BOUND ASOPRISNIL AND A PEPTIDE FROM THE CO-REPRESSOR NCOR |
| 2W8Y | B:698-909; B:698-909 | RU486 BOUND TO THE PROGESTERONE RECEPTOR IN A DESTABILIZED AGONISTIC CONFORMATION |
| 3KBA | B:698-909; B:698-909 | PROGESTERONE RECEPTOR BOUND TO SULFONAMIDE PYRROLIDINE PARTIAL AGONIST |
| 3KMR | A:207-406 | CRYSTAL STRUCTURE OF RARALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH AN AGONIST LIGAND (AM580) AND A COACTIVATOR FRAGMENT |
| 3KMZ | B:207-401; B:207-401 | CRYSTAL STRUCTURE OF RARALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH THE INVERSE AGONIST BMS493 AND A COREPRESSOR FRAGMENT |
| 1XAP | A:215-399 | STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOIC ACID RECEPTOR BETA |
| 3LBD | A:223-408 | LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO 9-CIS RETINOIC ACID |
| 1N83 | A:335-511 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE ORPHAN NUCLEAR HORMONE RECEPTOR ROR(ALPHA)-LBD AND CHOLESTEROL |
| 1S0X | A:335-511 | CRYSTAL STRUCTURE OF THE HUMAN RORALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH CHOLESTEROL SULFATE AT 2.2A |
| 3KYT | A:299-487 | CRYSTAL STRUCTURE OF ORPHAN NUCLEAR RECEPTOR RORGAMMA IN COMPLEX WITH NATURAL LIGAND |
| 3L0J | A:299-487 | CRYSTAL STRUCTURE OF ORPHAN NUCLEAR RECEPTOR RORGAMMA IN COMPLEX WITH NATURAL LIGAND |
| 3L0L | B:299-487; B:299-487 | CRYSTAL STRUCTURE OF ORPHAN NUCLEAR RECEPTOR RORGAMMA IN COMPLEX WITH NATURAL LIGAND |
| 1LBD | A:251-442 | LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA |
| 1MV9 | A:263-442 | CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE EICOSANOID DHA (DOCOSA HEXAENOIC ACID) AND A COACTIVATOR PEPTIDE |
| 1MVC | A:263-442 | CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE |
| 1MZN | G:3263-3442; G:3263-3442; G:3263-3442; G:3263-3442 | CRYSTAL STRUCTURE AT 1.9 ANGSTROEMS RESOLUTION OF THE HOMODIMER OF HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE |
| 1XLS | D:251-442; D:251-442; D:251-442; D:251-442 | CRYSTAL STRUCTURE OF THE MOUSE CAR/RXR LBD HETERODIMER BOUND TO TCPOBOP AND 9CRA AND A TIF2 PEPTIDE CONTAING THE THIRD LXXLL MOTIFS |
| 2P1U | A:263-442 | CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH 3-(2'-ETHOXY)-TETRAHYDRONAPHTYL CINNAMIC ACID AND A FRAGMENT OF THE COACTIVATOR TIF-2 |
| 2P1V | A:263-442 | CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH 3-(2'-PROPOXY)-TETRAHYDRONAPHTYL CINNAMIC ACID AND A FRAGMENT OF THE COACTIVATOR TIF-2 |
| 2ZXZ | A:262-442 | CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO A SYNTHETIC AGONIST COMPOUND AND A COACTIVATOR PEPTIDE |
| 2ZY0 | C:262-442; C:262-442 | CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO A SYNTHETIC AGONIST COMPOUND AND A COACTIVATOR PEPTIDE |
| 3KWY | A:263-442 | CRYSTAL STRUCTURE OF RXRALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH TRIPHENYLTIN AND A COACTIVATOR FRAGMENT |
| 3OAP | A:262-442 | CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH 9-CIS RETINOIC ACID AND THE COACTIVATOR PEPTIDE GRIP-1 |
| 3OZJ | C:262-442; C:262-442 | CRYSTAL STRUCTURE OF HUMAN RETINOIC X RECEPTOR ALPHA COMPLEXED WITH BIGELOVIN AND COACTIVATOR SRC-1 |
| 3R29 | B:263-442; B:263-442 | CRYSTAL STRUCTURE OF RXRALPHA LIGAND-BINDING DOMAIN COMPLEXED WITH COREPRESSOR SMRT2 |
| 3R2A | D:264-442; D:264-442; D:264-442; D:264-442 | CRYSTAL STRUCTURE OF RXRALPHA LIGAND-BINDING DOMAIN COMPLEXED WITH COREPRESSOR SMRT2 AND ANTAGONIST RHEIN |
| 1YOW | A:249-455 | HUMAN STEROIDOGENIC FACTOR 1 LBD WITH BOUND CO-FACTOR PEPTIDE |
| 1ZDT | B:249-455; B:249-455 | THE CRYSTAL STRUCTURE OF HUMAN STEROIDOGENIC FACTOR-1 |
| 1NAV | A:199-370 | THYROID RECEPTOR ALPHA IN COMPLEX WITH AN AGONIST SELECTIVE FOR THYROID RECEPTOR BETA1 |
| 3JZB | A:199-370 | CRYSTAL STRUCTURE OF TR-ALFA BOUND TO THE SELECTIVE THYROMIMETIC TRIAC |
| 1N46 | B:263-445; B:263-445 | CRYSTAL STRUCTURE OF HUMAN TR BETA LIGAND-BINDING DOMAIN COMPLEXED WITH A POTENT SUBTYPE-SELECTIVE THYROMIMETIC |
| 1NAX | A:257-445 | THYROID RECEPTOR BETA1 IN COMPLEX WITH A BETA-SELECTIVE LIGAND |
| 1NQ0 | A:263-445 | TR RECEPTOR MUTATIONS CONFERRING HORMONE RESISTANCE AND REDUCED COREPRESSOR RELEASE EXHIBIT DECREASED STABILITY IN THE NTERMINAL LBD |
| 1NUO | A:265-445 | TWO RTH MUTANTS WITH IMPAIRED HORMONE BINDING |
| 1Q4X | A:262-445 | CRYSTAL STRUCTURE OF HUMAN THYROID HORMONE RECEPTOR BETA LBD IN COMPLEX WITH SPECIFIC AGONIST GC-24 |
| 1R6G | A:264-445 | CRYSTAL STRUCTURE OF THE THYROID HORMONE RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A BETA SELECTIVE COMPOUND |
| 1XZX | X:264-445 | THYROXINE-THYROID HORMONE RECEPTOR INTERACTIONS |
| 1Y0X | X:264-445 | THYROXINE-THYROID HORMONE RECEPTOR INTERACTIONS |
| 2PIN | B:257-445; B:257-445 | THYROID RECEPTOR BETA IN COMPLEX WITH INHIBITOR |
| 3JZC | A:264-445 | CRYSTAL STRUCTURE OF TR-BETA BOUND TO THE SELECTIVE THYROMIMETIC TRIAC |
| 1S0Z | A:216-418 | CRYSTAL STRUCTURE OF THE VDR LBD COMPLEXED TO SEOCALCITOL. |
| 1S19 | A:216-418 | CRYSTAL STRUCTURE OF VDR LIGAND BINDING DOMAIN COMPLEXED TO CALCIPOTRIOL. |
| 1TXI | A:216-418 | CRYSTAL STRUCTURE OF THE VDR LIGAND BINDING DOMAIN COMPLEXED TO TX522 |
| 3M7R | A:216-418 | CRYSTAL STRUCTURE OF VDR H305Q MUTANT |
)
)